Lazard Asset Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
90,297
+87,021
| +2,656% | +$1.55M | ﹤0.01% | 1089 |
|
|
2025
Q1 | $58K | Sell |
3,276
-485
| -13% | -$8.59K | ﹤0.01% | 1963 |
|
|
2024
Q4 | $112K | Sell |
3,761
-22
| -0.6% | -$655 | ﹤0.01% | 1771 |
|
|
2024
Q3 | $59K | Buy |
3,783
+3,764
| +19,811% | +$58.7K | ﹤0.01% | 1888 |
|
|
2024
Q2 | $0 | Hold |
19
| – | – | ﹤0.01% | 2372 |
|
|
2024
Q1 | $0 | Hold |
19
| – | – | ﹤0.01% | 2273 |
|
|
2023
Q4 | $0 | Hold |
19
| – | – | ﹤0.01% | 2408 |
|
|
2023
Q3 | $0 | Hold |
19
| – | – | ﹤0.01% | 2417 |
|
|
2023
Q2 | $0 | Sell |
19
-1,027
| -98% | – | ﹤0.01% | 2474 |
|
|
2023
Q1 | $62K | Hold |
1,046
| – | – | ﹤0.01% | 1729 |
|
|
2022
Q4 | $76K | Hold |
1,046
| – | – | ﹤0.01% | 1629 |
|
|
2022
Q3 | $79K | Buy |
1,046
+1,038
| +12,975% | +$78.4K | ﹤0.01% | 1583 |
|
|
2022
Q2 | $0 | Sell |
8
-1,342
| -99% | – | ﹤0.01% | 2514 |
|
|
2022
Q1 | $111K | Buy |
1,350
+843
| +166% | +$69.3K | ﹤0.01% | 1367 |
|
|
2021
Q4 | $38K | Sell |
507
-14,659
| -97% | -$1.1M | ﹤0.01% | 1853 |
|
|
2021
Q3 | $1.76M | Buy |
15,166
+14,440
| +1,989% | +$1.68M | ﹤0.01% | 937 |
|
|
2021
Q2 | $161K | Sell |
726
-112
| -13% | -$24.8K | ﹤0.01% | 1244 |
|
|
2021
Q1 | $110K | Sell |
838
-132
| -14% | -$17.3K | ﹤0.01% | 1190 |
|
|
2020
Q4 | $167K | Sell |
970
-877
| -47% | -$151K | ﹤0.01% | 1121 |
|
|
2020
Q3 | $205K | Sell |
1,847
-323
| -15% | -$35.9K | ﹤0.01% | 965 |
|
|
2020
Q2 | $128K | Sell |
2,170
-502
| -19% | -$29.6K | ﹤0.01% | 971 |
|
|
2020
Q1 | $179K | Buy |
2,672
+2,079
| +351% | +$139K | ﹤0.01% | 914 |
|
|
2019
Q4 | $49K | Hold |
593
| – | – | ﹤0.01% | 1064 |
|
|
2019
Q3 | $44K | Buy |
+593
| New | +$44K | ﹤0.01% | 1009 |
|
|
2018
Q1 | – | Sell |
-13,425
| Closed | -$271K | – | 1090 |
|
|
2017
Q4 | $271K | Buy |
+13,425
| New | +$271K | ﹤0.01% | 851 |
|